New Pharma Opportunities And Market Access Challenges In Japan
概要
※本White paperは英語です
- Sources of market growth and real opportunities
- Orphan drug incentives
- New directions in pricing and reimbursement
- Recent regulatory environment
- Sales and distribution
- Market access with ICCC (in-country clinical caretaker)
SHARE